It would be an understatement to say Sarepta Therapeutics, Inc. (NASDAQ: SRPT ) and its investors have been through quite a ride over the last few years. Biotechnology stocks are no strangers to volatility, especially when many of their drugs are eitherDividends (DGI and DRIP) and Growth at reasonable price (GARP) for Long-term. Serious money.Fun trading for short-term. Play money.Ideas and thoughts presented in the articles are not professional recommendations.Analyst’s Disclosure:I/we have a beneficial lo ...